First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                       (Dr RN Tandon)
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
14th December, 2017
Straight from the Heart: Some Facts on Max-Fortis Cases

IMA got an access to part inquiry reports in the Fortis and the Max case, respectively. Here are some excerpts which should also be known to the medical fraternity

Fortis case: IMA Notes Based on inquiry report

  • “The committee found that the patient was suffering from Dengue Shock Syndrome, not mere dengue fever”.
  • “The mortality is high ranging from 6 to 30%. Most deaths occur in children”.
  • “The Committee found that the family had to spent Rs. 15.00 lakh for emergency ICU treatment for 15 days, not for dengue fever”
  • “There is prima facie no evidence of negligence in the management of the child during her stay in the PICU.”
  • “It is unlikely that conducting MRI earlier would have affected the course of treatment.”
  • “There are no guidelines on how many consumables are to be used per day in a PICU patient. However, general guidelines state that a liberal use of consumables for example syringes, gloves etc. must be made to decrease the risk of hospital acquired infections in these patients.”
To Read More or Comment, Click Here
Top News

New initiatives launched on Universal Health Coverage Day, 2017

At a function to observe Universal Health Coverage Day, 2017, the Union Health Minister and MoS (Finance) launched "LaQshya' - Labour Room Quality Improvement Initiative, a Safe Delivery Mobile Application for health workers who manage normal and complicated deliveries in the peripheral areas, and also released the Operational Guidelines for Obstetric High Dependency Units (HDUs) and Intensive Care Units (ICUs).... read more

“Every Try Counts”: US FDA campaign to encourage adult smokers trying to quit cigarettes

The US Food and Drug Administration (FDA) has launched an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. .... read more

Practice Updates
First drug for eosinophilic granulomatosis with polyangiitis

The US Food and Drug Administration (FDA) has expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, more

Healthy adults with normal LDL-C may also have subclinical atherosclerosis

Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors, says a study reported in the December 2017 issue of the Journal of the American College of Cardiology. more

USPSTF recommendation on HRT for primary prevention of chronic conditions in postmenopausal women

In a final recommendation statement on hormone therapy for the primary prevention of chronic conditions in postmenopausal women, the US Preventive Services Task Force (USPSTF) has recommended against hormone therapy for preventing chronic conditions in women who have gone through menopause, more

Omalizumab improves efficacy of oral immunotherapy for multiple food allergies

In multifood allergic patients, omalizumab improves the efficacy of multifood oral immunotherapy and enables safe and rapid desensitization. These conclusions from a study were published online December 11, 2017 in The Lancet Gastroenterology & more

US FDA approves raltegravir for treatment of HIV-1 in neonates

The US Food and Drug Administration (FDA) has expanded the indication of the HIV drug raltegravir (Isentress, Merck) beyond adults and children aged 2 to 18 years to newborns weighing at least 2 kg making it the only approved integrase inhibitor for HIV-1 treatment in this population group, more

Brain MRI scan may identify epilepsy patients at risk of sudden death

MRI brain scan can detect potentially life-threatening brainstem damage in patients with epilepsy and thus identify patients at risk for sudden unexpected death in epilepsy (SUDEP), according to a study presented December 4, more

eMedi Humor
Medicolegal Corner
eMedi Quiz
1. Macular edema.
2. Sympathetic ophthalmia.
3. Optic nerve avulsion.
4. Delayed vitreous hemorrhage.
Lifestyle Updates
Inspirational Story 1: : Follow your dream
Inspirational Story 2: It pays to be patient
Seasonal flu to hit India hard in the coming year
It is imperative to get vaccinated in a timely manner to avoid getting infected
New Delhi, 13 December 2017: Seasonal influenza outbreaks each year cause 3 million to 5 million severe cases and 300,000 to 500,000 deaths globally, estimates the WHO. Recent predictions by flu-trackers have indicated that seasonal flu will hit India and the rest of the northern hemisphere hard next year. This prediction is based on outbreak trends in the winter of the southern hemisphere, where Australia has reported record-high numbers of cases, hospitalizations and deaths.
Seasonal flu shows a minor peak from December to February in India. It causes symptoms of fever, cough, breathlessness, lethargy, headache and nausea. Most people recover within a week without ill-effects, but complications such as pneumonia and multi-organ failure can kill people at risk, such as young children with respiratory problems,
To Read More or Comment, Click Here